Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Bupivacaine in Labor Analgesia
NCT06550414Completed
- Sponsor
- Services Institute of Medical Sciences
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in labor pain (2 arms), sponsored by Services Institute of Medical Sciences. Primary endpoint: Onset of Analgesia at 45 minutes. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT06550414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06550414.